Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied
Oct 15, 2014
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy, CTL019.